Bioengineered Let-7c Inhibits Orthotopic Hepatocellular Carcinoma and Improves Overall Survival with Minimal Immunogenicity-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Bioengineered Let-7c Inhibits Orthotopic Hepatocellular Carcinoma and Improves Overall Survival with Minimal Immunogenicity

Published:2019-03 Issue: Volume:14 Page:498-508
ISSN:2162-2531
Container-title:Molecular Therapy - Nucleic Acids
language:en
Short-container-title:Molecular Therapy - Nucleic Acids

Author:

Jilek Joseph L.,Zhang Qian-Yu,Tu Mei-Juan,Ho Pui Yan,Duan Zhijian,Qiu Jing-Xin,Yu Ai-Ming

Funder

National Institute of General Medical Sciences

National Cancer Institute

NIH

NIGMS

Pharmacology Training Program

UC Davis Comprehensive Cancer Center

Publisher

Elsevier BV

Subject

Drug Discovery,Molecular Medicine

Reference55 articles.

1. Cancer statistics, 2018;Siegel;CA Cancer J. Clin.,2018

2. Temporal trends in disease presentation and survival of patients with hepatocellular carcinoma: a real-world experience from 1998 to 2015;Kim;Cancer,2018

3. Immunotherapy of hepatocellular carcinoma: facts and hopes;Iñarrairaegui;Clin. Cancer Res.,2018

4. Regorafenib for patients with hepatocellular carcinoma who progressed on sorafenib treatment (RESORCE): a randomised, double-blind, placebo-controlled, phase 3 trial;Bruix;Lancet,2017

5. Sorafenib in advanced hepatocellular carcinoma;Llovet;N. Engl. J. Med.,2008

Cited by 32 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efflux ABC transporters in drug disposition and their posttranscriptional gene regulation by microRNAs;Frontiers in Pharmacology;2024-07-24

2. Molecular Engineering of Functional SiRNA Agents;ACS Synthetic Biology;2024-05-11

3. Novel RNA molecular bioengineering technology efficiently produces functional miRNA agents;RNA;2024-03-01

4. Use of recombinant microRNAs as antimetabolites to inhibit human non-small cell lung cancer;Acta Pharmaceutica Sinica B;2023-10

5. Bioengineered chimeric tRNA/pre‐miRNAs as prodrugs in cancer therapy;Biotechnology Progress;2023-08-22

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3